Drugs / CCK
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02748525 Background | May 2016 → Jun 2018 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CCK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02748525 ↗ |
| Modality | Peptide | “CCK a physiologic peptide enzyme produced in the duodenum” NCT02748525 ↗ |
| Route | Intravenous | “It is given intravenously” NCT02748525 ↗ |